Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092960 · ClinicalTrials.gov registry record · NA
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
A NA study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- NA
- Development phase
- 424
- Enrollment target
NCT03092960 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 424 participants.
The verdict
NCT03092960, a NA study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 424 participants
- Enrollment target
Study Summary
The purpose of this study is to test a flexible lifestyle program designed to help Latino men make healthy lifestyle changes to lower their risk of developing diabetes and heart disease. The program is called HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas; English translation: Men with choices to improve well being and decrease chronic disease risk).
Interventions
- BEHAVIORAL Minimal intensity intervention
- BEHAVIORAL HOMBRE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092960
The ClinicalTrials.gov registry entry for NCT03092960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 424 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Medical Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Minimal intensity intervention is the first listed.
NCT03092960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03092960 about?
NCT03092960 is a clinical study titled "The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men". The purpose of this study is to test a flexible lifestyle program designed to help Latino men make healthy lifestyle changes to lower their risk of developing diabetes and heart disease. The program is called HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades cr...
What is the current status of trial NCT03092960?
This trial is currently completed. It is a NA study. The enrollment target is 424 participants. The study started on 2017-04-03. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03092960?
The interventions under investigation include: Minimal intensity intervention (BEHAVIORAL), HOMBRE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092960?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.